Status update after one year as listed company

AcouSort AB reports in a press release on 23 January 2017 its update on current strategic projects and other commercialization activities after one year as publicly listed company. The press release primarily addresses the following elements: After four successful feasibility studies together with OEM-partner I targeting acoustic blood plasma separation for a clinical diagnostic application,… Read more »

Read More

Invention acquired from Technical University Denmark

AcouSort has today announced the full acquisition from Technical University of Denmark (DTU) of an invention targeting the application of polymers in acoustofluidcs devices. The invention was made by researchers at DTU headed by Professor Henrik Bruus, DTU Physics in collaboration with AcouSort. You may read more details in the full press release (in Swedish)… Read more »

Read More

Term sheet in place for first Commercialization Agreement

AcouSort and one of its lifescience partners (OEM Partner 1) have agreed on a non-binding Term Sheet to serve as the basis for a formal Commercialization Agreement for using AcouSort IP in future new versions of one of the Partner’s current main product families. According to the Term Sheet, the Partner will exclusively license AcouSort… Read more »

Read More